Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
5WUX
DownloadVisualize
BU of 5wux by Molmil
TNFalpha-certolizumab Fab
Descriptor: Tumor necrosis factor alpha, heavy, light
Authors:Heo, Y.S, Lee, J.U.
Deposit date:2016-12-21
Release date:2017-06-07
Method:X-RAY DIFFRACTION (2.9 Å)
Cite:Molecular Basis for the Neutralization of Tumor Necrosis Factor alpha by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
Int J Mol Sci, 18, 2017
5WUV
DownloadVisualize
BU of 5wuv by Molmil
Crystal structure of Certolizumab Fab
Descriptor: heavy chain, light chain
Authors:Heo, Y.S, Lee, J.U, Son, J.Y, Shin, W, Yoo, K.Y.
Deposit date:2016-12-21
Release date:2017-06-07
Method:X-RAY DIFFRACTION (1.952 Å)
Cite:Molecular Basis for the Neutralization of Tumor Necrosis Factor alpha by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
Int J Mol Sci, 18, 2017
4Y7I
DownloadVisualize
BU of 4y7i by Molmil
Crystal Structure of MTMR8
Descriptor: Myotubularin-related protein 8, PHOSPHATE ION
Authors:Yoo, K, Lee, J, Son, J, Shin, W, Im, D, Heo, Y.S.
Deposit date:2015-02-15
Release date:2015-07-15
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.802 Å)
Cite:Structure of the catalytic phosphatase domain of MTMR8: implications for dimerization, membrane association and reversible oxidation.
Acta Crystallogr.,Sect.D, 71, 2015
5GGU
DownloadVisualize
BU of 5ggu by Molmil
Crystal structure of tremelimumab Fab
Descriptor: heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (2.292 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGS
DownloadVisualize
BU of 5ggs by Molmil
PD-1 in complex with pembrolizumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.997 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGV
DownloadVisualize
BU of 5ggv by Molmil
CTLA-4 in complex with tremelimumab Fab
Descriptor: Cytotoxic T-lymphocyte protein 4, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.998 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGT
DownloadVisualize
BU of 5ggt by Molmil
PD-L1 in complex with BMS-936559 Fab
Descriptor: IGK@ protein, IgG H chain, Programmed cell death 1 ligand 1
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGR
DownloadVisualize
BU of 5ggr by Molmil
PD-1 in complex with nivolumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (3.3 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGQ
DownloadVisualize
BU of 5ggq by Molmil
Crystal structure of Nivolumab Fab fragment
Descriptor: nivolumab heavy chain, nivolumab light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5Y9J
DownloadVisualize
BU of 5y9j by Molmil
BAFF in complex with belimumab
Descriptor: Tumor necrosis factor ligand superfamily member 13B, belibumab light chain, belimumab heavy chain
Authors:Heo, Y.-S, Shin, W.
Deposit date:2017-08-25
Release date:2018-02-21
Last modified:2019-09-04
Method:X-RAY DIFFRACTION (2.05 Å)
Cite:BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
Nat Commun, 9, 2018
5Y9K
DownloadVisualize
BU of 5y9k by Molmil
Structure of the belimumab Fab fragment
Descriptor: belimumab heavy chain, belimumab light chain
Authors:Heo, Y.-S, Shin, W.
Deposit date:2017-08-25
Release date:2018-02-21
Last modified:2019-09-04
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
Nat Commun, 9, 2018

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon